Dodge & Cox Novartis Ag Transaction History

Dodge & Cox

$163 Billion
Q1 2024

A detailed history of Dodge & Cox transactions in Novartis Ag stock. As of the latest transaction made, Dodge & Cox holds 12,353,985 shares of NVS stock, worth $1.27 Billion. This represents 0.73% of its overall portfolio holdings.

Number of Shares

12,353,985

Previous 13,165,538 6.16%

Holding current value

$1.27 Billion

Previous $1.33 Billion 10.1%

% of portfolio

0.73%

Previous 0.88%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$95.27 - $108.47 $77.3 Million - $88 Million	-811,553 Reduced 6.16%	12,353,985 $1.2 Billion
Q4 2023 Feb 15, 2024	SELL	$92.27 - $101.54 $286 Million - $315 Million	-3,098,683 Reduced 19.05%	13,165,538 $1.33 Billion
Q3 2023 Nov 14, 2023	SELL	$94.73 - $105.13 $13.5 Million - $15 Million	-142,892 Reduced 0.87%	16,264,221 $1.66 Billion
Q2 2023 Aug 14, 2023	SELL	$92.52 - $104.91 $361 Million - $410 Million	-3,905,567 Reduced 19.23%	16,407,113 $1.66 Billion
Q1 2023 May 12, 2023	SELL	$80.03 - $92.81 $35.1 Million - $40.7 Million	-438,692 Reduced 2.11%	20,312,680 $1.87 Billion

Q4 2022 Feb 14, 2023	SELL	$75.55 - $92.52 $22.5 Million - $27.5 Million	-297,285 Reduced 1.41%	20,751,372 $1.88 Billion
Q3 2022 Nov 10, 2022	SELL	$74.61 - $87.26 $112 Million - $131 Million	-1,504,112 Reduced 6.67%	21,048,657 $1.6 Billion
Q2 2022 Aug 12, 2022	SELL	$80.52 - $93.75 $426 Million - $496 Million	-5,291,440 Reduced 19.0%	22,552,769 $1.91 Billion
Q1 2022 May 13, 2022	SELL	$80.11 - $90.62 $32.5 Million - $36.7 Million	-405,331 Reduced 1.43%	27,844,209 $2.44 Billion
Q4 2021 Feb 14, 2022	SELL	$79.7 - $88.13 $81 Million - $89.6 Million	-1,016,360 Reduced 3.47%	28,249,540 $2.47 Billion
Q3 2021 Nov 15, 2021	BUY	$81.78 - $95.14 $394 Million - $458 Million	4,812,635 Added 19.68%	29,265,900 $2.39 Billion
Q2 2021 Aug 13, 2021	BUY	$85.24 - $94.15 $237 Million - $262 Million	2,783,028 Added 12.84%	24,453,265 $2.23 Billion
Q1 2021 May 14, 2021	BUY	$83.5 - $98.47 $4.55 Million - $5.36 Million	54,436 Added 0.25%	21,670,237 $1.85 Billion
Q4 2020 Feb 11, 2021	SELL	$78.07 - $94.43 $13.7 Million - $16.6 Million	-175,374 Reduced 0.8%	21,615,801 $2.04 Billion
Q3 2020 Nov 13, 2020	BUY	$82.14 - $91.0 $200 Million - $222 Million	2,437,388 Added 12.59%	21,791,175 $1.89 Billion
Q2 2020 Aug 13, 2020	SELL	$80.93 - $91.1 $290 Million - $327 Million	-3,587,653 Reduced 15.64%	19,353,787 $1.69 Billion
Q1 2020 May 14, 2020	SELL	$70.67 - $99.01 $160 Million - $224 Million	-2,264,141 Reduced 8.98%	22,941,440 $1.89 Billion
Q4 2019 Feb 13, 2020	SELL	$84.35 - $95.37 $132 Million - $149 Million	-1,563,295 Reduced 5.84%	25,205,581 $2.39 Billion
Q3 2019 Nov 13, 2019	SELL	$85.54 - $94.26 $227 Million - $250 Million	-2,655,693 Reduced 9.03%	26,768,876 $2.33 Billion
Q2 2019 Aug 13, 2019	SELL	$75.4 - $92.8 $522 Million - $642 Million	-6,920,026 Reduced 19.04%	29,424,569 $2.69 Billion
Q1 2019 May 14, 2019	SELL	$75.32 - $86.15 $34.2 Million - $39.1 Million	-454,023 Reduced 1.23%	36,344,595 $3.49 Billion
Q4 2018 Feb 14, 2019	SELL	$73.66 - $82.02 $557 Million - $620 Million	-7,562,769 Reduced 17.05%	36,798,618 $3.16 Billion
Q3 2018 Nov 14, 2018	BUY	$66.94 - $77.43 $15.4 Million - $17.8 Million	229,525 Added 0.52%	44,361,387 $3.82 Billion
Q2 2018 Aug 14, 2018	SELL	$64.91 - $73.36 $10.9 Million - $12.3 Million	-168,300 Reduced 0.38%	44,131,862 $3.33 Billion
Q1 2018 May 14, 2018	SELL	$70.39 - $84.15 $19.7 Million - $23.5 Million	-279,225 Reduced 0.63%	44,300,162 $3.58 Billion
Q4 2017 Feb 14, 2018	SELL	$72.33 - $77.64 $4.67 Million - $5.01 Million	-64,538 Reduced 0.14%	44,579,387 $3.74 Billion
Q3 2017 Nov 13, 2017	BUY	$74.14 - $77.27 $3.31 Billion - $3.45 Billion	44,643,925	44,643,925 $3.83 Billion

Others Institutions Holding NVS

# of Institutions

1,342

Shares Held

140M

Call Options Held

1.15M

Put Options Held

866K

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $222B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dodge & Cox, based on Form 13F filings with the SEC.

News

Stay updated on Dodge & Cox with notifications on news.

Account